Therapeutic Potential of Selenium in Glioblastoma
Open Access
- 28 May 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neuroscience
Abstract
Little progress has been made in the long-term management of malignant brain tumors, leaving patients with glioblastoma, unfortunately, with a fatal prognosis. Glioblastoma remains the most aggressive primary brain cancer in adults. Similar to other cancers, glioblastoma undergoes a cellular metabolic reprogramming to form an oxidative tumor microenvironment, thereby fostering proliferation, angiogenesis and tumor cell survival. Latest investigations revealed that micronutrients, such as selenium, may have positive effects in glioblastoma treatment, providing promising chances regarding the current limitations in surgical treatment and radiochemotherapy outcomes. Selenium is an essential micronutrient with anti-oxidative and anti-cancer properties. There is additional evidence of Se deficiency in patients suffering from brain malignancies, which increases its importance as a therapeutic option for glioblastoma therapy. It is well known that selenium, through selenoproteins, modulates metabolic pathways and regulates redox homeostasis. Therefore, selenium impacts on the interaction in the tumor microenvironment between tumor cells, tumor-associated cells and immune cells. In this review we take a closer look at the current knowledge about the potential of selenium on glioblastoma, by focusing on brain edema, glioma-related angiogenesis, and cells in tumor microenvironment such as glioma-associated microglia/macrophages.This publication has 171 references indexed in Scilit:
- Selenium Supplementation Restores Innate and Humoral Immune Responses in Footrot-Affected SheepPLOS ONE, 2013
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Analysis of Tumor Metabolism Reveals Mitochondrial Glucose Oxidation in Genetically Diverse Human Glioblastomas in the Mouse Brain In VivoCell Metabolism, 2012
- Coactivation of NMDA Receptors by Glutamate and d-Serine Induces Dilation of Isolated Middle Cerebral ArteriesJournal of Cerebral Blood Flow & Metabolism, 2011
- Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxibChemico-Biological Interactions, 2010
- Selenium-containing analogs of SAHA induce cytotoxicity in lung cancer cellsBioorganic & Medicinal Chemistry Letters, 2010
- Role of selenium-containing proteins in T-cell and macrophage functionProceedings of the Nutrition Society, 2010
- SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitorsBioorganic & Medicinal Chemistry Letters, 2010
- Synthesis and Anticancer Activity Comparison of Phenylalkyl Isoselenocyanates with Corresponding Naturally Occurring and Synthetic IsothiocyanatesJournal of Medicinal Chemistry, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006